Research Interests 【 display / non-display 】

Research Interests 【 display / non-display 】

display all >>

Graduating School 【 display / non-display 】

Graduating School 【 display / non-display 】

• 　

  -

  2012.03

  Akita University   Faculty of Medicine   Graduated

Graduate School 【 display / non-display 】

Graduate School 【 display / non-display 】

• 　

  -

  2018.03

  Akita University  Graduate School, Division of Medicine  Doctor's Course  Completed

Campus Career 【 display / non-display 】

Campus Career 【 display / non-display 】

• 2021.10

  -

  Now

  Akita University   Graduate School of Medicine   Doctorial Course in Medicine   Bioregulatory Medicine   Department of Radiology   Lecturer  

• 2018.04

  -

  2021.09

  Akita University   Graduate School of Medicine   Doctorial Course in Medicine   Bioregulatory Medicine   Department of Radiology   Assistant Professor  

External Career 【 display / non-display 】

External Career 【 display / non-display 】

• 2018.04

  -

  2021.09

  Akita University Graduate School of Medicine   Radiology   Assistant Professor  

• 2017.05

  -

  2018.03

  Akita University Hospital   Radiation Oncology   Doctor  

• 2016.11

  -

  2017.04

  Southern TOHOKU Proton Therapy Center   Medical Staff  

• 2016.11

  -

  2017.04

  Southern TOHOKU Proton Theryapy Center   Radiation Oncology   Doctor  

• 2014.04

  -

  2016.10

  Akita University Hospital   Medical Staff  

display all >>

Research Areas 【 display / non-display 】

Research Areas 【 display / non-display 】

• Life Science / Radiological sciences

• Life Science / Radiological sciences

• Life Science / Tumor diagnostics and therapeutics

Qualification acquired 【 display / non-display 】

Qualification acquired 【 display / non-display 】

• Radiation Oncologist

• Interventional Radiologist

Thesis for a degree 【 display / non-display 】

Thesis for a degree 【 display / non-display 】

• Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.

  Yuki Wada, Katsumi Hirose, Takaomi Harada et al. 

  Journal of Radiation Research  59 ( 2 ) 122 - 128   2018.03  [Refereed]

  Domestic Co-author

Research Achievements 【 display / non-display 】

Research Achievements 【 display / non-display 】

◆Original paper【 display / non-display 】

To the head of this page.▲

◆Original paper【 display / non-display 】

Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer

Yuki Wada, Satoshi Kumagai, Noriko Takagi, Tetsugaku Shinozaki, Toshiki Murata, Daichi Sugawara, Kenta Watanabe, Tamotsu Matsuhashi, Katsunori Iijima, Naoko Mori

Journal of Gastroenterology ( Springer Science and Business Media LLC )  60 ( 1 ) 32 - 42   2024.10  [Refereed]

Research paper (journal)  

DOI

Interruption during drug-eluting beads transarterial chemoembolization procedure by presumed allergic shock requires careful follow-up on the development of vascular lake phenomenon

Ogawa, Akihiro a; Wada, Yuki a; Iijima, Katsunori b; Mori, Naoko

Journal of Clinical Imaging Science ( Journal of Clinical Imaging Science )  14 ( 1 )   2024.08  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

Tumor diameter and enhancing capsule, as well as previous interventional treatments, as potential predictors of vascular lake phenomenon in hepatocellular carcinoma patients treated with drug-eluting beads transarterial chemoembolization

Kento Hatakeyama, Tomoki Tozawa, Yuki Wada, Motoko Konno, Masazumi Matsuda, Takahiro Otani, Shinichiro Minami, Wataru Sato, Kyoko Nomura, Katsunori Iijima, Naoko Mori

Journal of Clinical Imaging Science ( Scientific Scholar )  14   29 - 29   2024.08  [Refereed]

Research paper (journal)  

Objectives:

The initial drug-eluting bead (DEB)-transarterial chemoembolization (TACE) are often performed after multiple sessions of transarterial infusion chemotherapy (TAI) or conventional TACE. The purpose of our study was to evaluate the factors associated with the occurrence of vascular lake phenomenon (VLP) during DEB-TACE, considering the previous interventional treatments.

Material and Methods:

Forty-nine initial DEB-TACE procedures in 49 patients between November 2010 and April 2024 were included in this retrospective study. VLP was defined as a localized pooling of contrast agents within the tumor in the venous phase of digital subtraction angiography. The laboratory data, pre-treatment imaging findings such as the maximum tumor diameter (≥3 cm or <3 cm) and the presence of enhancing capsule obtained from computed tomography or magnetic resonance imaging, size of DEBs, and loading drugs, the total number of previous interventional treatments were recorded and compared between VLP occurrence and VLP non-occurrence groups. The multivariate logistic regression analysis was performed to explore the association of factors in predicting VLP occurrence.

Results:

VLP was observed in 16 patients (32.65%) out of 49 patients. The maximum tumor diameter (≥3 cm) and the presence of the enhancing capsule were significantly higher, and the total number of previous interventional treatments was significantly smaller in the VLP occurrence group than in the VLP non-occurrence group (P = 0.0006, 0.0007, and 0.0003). In multivariate analysis, the maximum tumor diameter, the presence of the enhancing capsule, and the total number of previous interventional treatments were significantly associated with the occurrence of VLP (P = 0.0048, 0.0093, and 0.047).

Conclusion:

Our study confirmed that the reported risk factor, the maximum tumor diameter, and the enhancing capsule were significantly related to the occurrence of VLP in DEB-TACE. Further, the occurrence of VLP might be carefully considered when the number of previous interventional treatments is small.

DOI

Quality of palliative radiotherapy assessed using quality indicators: a multicenter survey

Tetsuo Saito, Naoto Shikama, Takeo Takahashi, Naoki Nakamura, Takashi Mori, Kaori Nakajima, Masahiko Koizumi, Shuhei Sekii, Takeshi Ebara, Hiroki Kiyohara, Keiko Higuchi, Atsunori Yorozu, Takeshi Nishimura, Yasuo Ejima, Hideyuki Harada, Norio Araki, Misako Miwa, Kazunari Yamada, Terufumi Kawamoto, Nobuki Imano, Joichi Heianna, Miwako Nozaki, Yuki Wada, Yu Ohkubo, Nobue Uchida, Miho Watanabe, Takashi Kosugi, Kazunari Miyazawa, Shigeo Yasuda, Hiroshi Onishi

Journal of Radiation Research ( Oxford University Press (OUP) )  rrae048 ( 4 ) 532 - 539   2024.06  [Refereed]

Research paper (journal)   Domestic Co-author

Abstract

We sought to identify potential evidence-practice gaps in palliative radiotherapy using quality indicators (QIs), previously developed using a modified Delphi method. Seven QIs were used to assess the quality of radiotherapy for bone metastases (BoM) and brain metastases (BrM). Compliance rate was calculated as the percentage of patients for whom recommended medical care was conducted. Random effects models were used to estimate the pooled compliance rates. Of the 39 invited radiation oncologists, 29 (74%) from 29 centers participated in the survey; 13 (45%) were academic and 16 (55%) were non-academic hospitals. For the QIs, except for BoM-4, the pooled compliance rates were higher than 80%; however, for at least some of the centers, the compliance rate was lower than these pooled rates. For BoM-4 regarding steroid use concurrent with radiotherapy for malignant spinal cord compression, the pooled compliance rate was as low as 32%. For BoM-1 regarding the choice of radiation schedule, the compliance rate was higher in academic hospitals than in non-academic hospitals (P = 0.021). For BrM-3 regarding the initiation of radiotherapy without delay, the compliance rate was lower in academic hospitals than in non-academic hospitals (P = 0.016). In conclusion, overall, compliance rates were high; however, for many QIs, practice remains to be improved in at least some centers. Steroids are infrequently used concurrently with radiotherapy for malignant spinal cord compression.

DOI

Interruption during drug-eluting beads transarterial chemoembolization procedure by presumed allergic shock requires careful follow-up on the development of vascular lake phenomenon

Akihiro Ogawa, Yuki Wada, Katsunori Iijima, Naoko Mori

Journal of Clinical Imaging Science   14 ( 27 )   2024  [Refereed]

Research paper (journal)  

display all >>

To the head of this page.▲

◆Other【 display / non-display 】

To the head of this page.▲

◆Other【 display / non-display 】

In Regard to Hirose and Sato

Yuki Wada, Naoko Mori

International Journal of Radiation Oncology Biology Physics ( International Journal of Radiation Oncology Biology Physics )  120 ( 3 )   2024.11  [Refereed]

Prompt report, short report, and research note, etc. (scientific journal)   Domestic Co-author

DOI

In Regard to Kil et al

Yuki Wada, Tetsugaku Shinozaki, Toshiki Murata, Satoshi Kumagai, Noriko Takagi, Naoko Mori

Advances in Radiation Oncology ( Elsevier BV )  8 ( 5 ) 101293 - 101293   2023.09  [Refereed]

Prompt report, short report, and research note, etc. (scientific journal)   Domestic Co-author

DOI

Re.: “A Systematic Review of the Safety and Efficacy of Stenting of the Inferior Vena Cava”

Noriko Takagi, Yuri Wada, Naoko Mori

European Journal of Vascular and Endovascular Surgery ( Elsevier BV )  66 ( 2 )   2023.04  [Refereed]

Prompt report, short report, and research note, etc. (scientific journal)  

DOI

Regarding “Final Analysis of Diagnostic Endoscopic Resection Followed by Selective Chemoradiotherapy for Stage I Esophageal Cancer”

Yuki Wada, Naoko Mori

Gastroenterology ( Elsevier BV )  165 ( 2 ) 518 - 519   2022.11  [Refereed]

Prompt report, short report, and research note, etc. (scientific journal)   Domestic Co-author

DOI

PALLIATIVE REIRRADIATION WITH AN ACCUMULATED DOSE OF 80 GY FOR PAINFUL BRACHIAL PLEXUS METASTASIS AFTER 60 GY IRRADIATION FOR LYMPH NODE METASTASIS OF BREAST CNACER: A CASE REPORT

Yuki Wada, Akira Anbai, Noriko Takagi, Tomoki Tozawa, Satoshi Kumagai, Eriko Okuyama, Kento Hatakeyama, Makoto Niwa, Manabu Hashimoto

Akita Journal of Medicine   48 ( 5 ) 47 - 53   2021.11

DOI CiNii Research

display all >>

Grant-in-Aid for Scientific Research 【 display / non-display 】

Grant-in-Aid for Scientific Research 【 display / non-display 】

• Grant-in-Aid for Early-Career Scientists

  Project Year： 2022.04  -  2025.03 

Presentations 【 display / non-display 】

Presentations 【 display / non-display 】

• Major modification of metastasis and palliative radiotherapy

   [Invited]

  2024.11  -  2024.11 

• What can we do to provide radiotherapy to more patients in need?

   [Invited]

  2024.11  -  2024.11 

• The usefulness of dual-energy CT in palliative irradiation of osteolytic spinal metastases

  2022.11  -  2022.11 

• The usefulness of dual-energy CT in palliative irradiation of osteolytic spinal metastases

  2022.11  -  2022.11 

• Two cases of progressive tongue cancers palliatively treated by selective transchateter arterial infusion

  Yuki Wada, Aoi Otaka, Takaharu Miyauchi, Manabu Hashimoto, Naoko Fukui, Hiromoto Kimura

  2019.05  -  2019.05 

display all >>

Teaching Experience 【 display / non-display 】

Teaching Experience 【 display / non-display 】

• 2024.04

  -

  Now

• 2024.04

  -

  Now

• 2023.05

  　

  　

• 2023

  -

  Now

• 2022

  -

  Now

display all >>

Academic Activity 【 display / non-display 】

Academic Activity 【 display / non-display 】

• 2025.03

  -

  Now

• 2025.01

  -

  Now

• 2024.09

  -

  Now

• 2023.07

  -

  Now

• 2023.07

  -

  Now

display all >>